schliessen

Filtern

 

Bibliotheken

Posttransplant malaria

The frequency and clinical characteristics of plasmodium infection were reported in 420 renal transplant recipients who were followed in the Transplantation Unit and Out-Patient Clinic of the Medical School of Istanbul. Plasmodium infection was diagnosed in eleven (9 male, 2 female) of the 420 patie... Full description

Journal Title: Transplantation 27 November 1996, Vol.62(10), pp.1521-3
Main Author: Türkmen, A
Other Authors: Sever, M S , Ecder, T , Yildiz, A , Aydin, A E , Erkoç, R , Eraksoy, H , Eldegez, U , Ark, E
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0041-1337 ; PMID: 8958286 Version:1
Link: http://pubmed.gov/8958286
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline8958286
title: Posttransplant malaria
format: Article
creator:
  • Türkmen, A
  • Sever, M S
  • Ecder, T
  • Yildiz, A
  • Aydin, A E
  • Erkoç, R
  • Eraksoy, H
  • Eldegez, U
  • Ark, E
subjects:
  • Kidney Transplantation -- Adverse Effects
  • Malaria -- Etiology
ispartof: Transplantation, 27 November 1996, Vol.62(10), pp.1521-3
description: The frequency and clinical characteristics of plasmodium infection were reported in 420 renal transplant recipients who were followed in the Transplantation Unit and Out-Patient Clinic of the Medical School of Istanbul. Plasmodium infection was diagnosed in eleven (9 male, 2 female) of the 420 patients (2.6%). Ten of the patients were transplanted in India, and one in our institution. The mean duration between the transplantation and the diagnosis of malaria was 21.7 + 44.4 days in patients who were transplanted in India. All of the patients were taking triple immunosuppressive drugs (CsA, AZA, PRED). Plasmodium falciparum was diagnosed in 6 patients, P vivax in 1 patient and P malariae in 1 patient. Also mixed infection with P falciparum and P malariae was diagnosed in 3 patients. After definite diagnosis, the patients were hospitalized. Chloroquine phosphate plus primaquine phosphate was administered for P vivax infection, whereas chloroquine phosphate alone was given for P falciparum and P malariae infection as a first line antimalarial therapy. As a result of therapy, infection improved clinically and the plasmodia disappeared rapidly from the thick blood film in 10 of the patients. Severe hemolysis and acute renal failure developed in one patient, who improved after hemodialysis therapy and exchange transfusions. It was concluded that malaria is quite a frequent infection of transplant recipients who get their allografts from donors living in high-risk areas, and all transplant recipients having this kind of transplantations should be suspected and examined for malaria. This may help to diagnose and treat the complication in the early period, thus resulting in an improved prognosis for this potentially life-threatening complication of the posttransplant period.
language: eng
source:
identifier: ISSN: 0041-1337 ; PMID: 8958286 Version:1
fulltext: fulltext
issn:
  • 00411337
  • 0041-1337
url: Link


@attributes
ID912337384
RANK0.06999999
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid8958286
sourceidmedline
recordidTN_medline8958286
sourceformatXML
sourcesystemPC
pqid78615533
display
typearticle
titlePosttransplant malaria
creatorTürkmen, A ; Sever, M S ; Ecder, T ; Yildiz, A ; Aydin, A E ; Erkoç, R ; Eraksoy, H ; Eldegez, U ; Ark, E
ispartofTransplantation, 27 November 1996, Vol.62(10), pp.1521-3
identifierISSN: 0041-1337 ; PMID: 8958286 Version:1
subjectKidney Transplantation -- Adverse Effects ; Malaria -- Etiology
descriptionThe frequency and clinical characteristics of plasmodium infection were reported in 420 renal transplant recipients who were followed in the Transplantation Unit and Out-Patient Clinic of the Medical School of Istanbul. Plasmodium infection was diagnosed in eleven (9 male, 2 female) of the 420 patients (2.6%). Ten of the patients were transplanted in India, and one in our institution. The mean duration between the transplantation and the diagnosis of malaria was 21.7 + 44.4 days in patients who were transplanted in India. All of the patients were taking triple immunosuppressive drugs (CsA, AZA, PRED). Plasmodium falciparum was diagnosed in 6 patients, P vivax in 1 patient and P malariae in 1 patient. Also mixed infection with P falciparum and P malariae was diagnosed in 3 patients. After definite diagnosis, the patients were hospitalized. Chloroquine phosphate plus primaquine phosphate was administered for P vivax infection, whereas chloroquine phosphate alone was given for P falciparum and P malariae infection as a first line antimalarial therapy. As a result of therapy, infection improved clinically and the plasmodia disappeared rapidly from the thick blood film in 10 of the patients. Severe hemolysis and acute renal failure developed in one patient, who improved after hemodialysis therapy and exchange transfusions. It was concluded that malaria is quite a frequent infection of transplant recipients who get their allografts from donors living in high-risk areas, and all transplant recipients having this kind of transplantations should be suspected and examined for malaria. This may help to diagnose and treat the complication in the early period, thus resulting in an improved prognosis for this potentially life-threatening complication of the posttransplant period.
languageeng
source
version3
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/8958286$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Türkmen, A
1Sever, M S
2Ecder, T
3Yildiz, A
4Aydin, A E
5Erkoç, R
6Eraksoy, H
7Eldegez, U
8Ark, E
titlePosttransplant malaria
descriptionThe frequency and clinical characteristics of plasmodium infection were reported in 420 renal transplant recipients who were followed in the Transplantation Unit and Out-Patient Clinic of the Medical School of Istanbul. Plasmodium infection was diagnosed in eleven (9 male, 2 female) of the 420 patients (2.6%). Ten of the patients were transplanted in India, and one in our institution. The mean duration between the transplantation and the diagnosis of malaria was 21.7 + 44.4 days in patients who were transplanted in India. All of the patients were taking triple immunosuppressive drugs (CsA, AZA, PRED). Plasmodium falciparum was diagnosed in 6 patients, P vivax in 1 patient and P malariae in 1 patient. Also mixed infection with P falciparum and P malariae was diagnosed in 3 patients. After definite diagnosis, the patients were hospitalized. Chloroquine phosphate plus primaquine phosphate was administered for P vivax infection, whereas chloroquine phosphate alone was given for P falciparum and P malariae infection as a first line antimalarial therapy. As a result of therapy, infection improved clinically and the plasmodia disappeared rapidly from the thick blood film in 10 of the patients. Severe hemolysis and acute renal failure developed in one patient, who improved after hemodialysis therapy and exchange transfusions. It was concluded that malaria is quite a frequent infection of transplant recipients who get their allografts from donors living in high-risk areas, and all transplant recipients having this kind of transplantations should be suspected and examined for malaria. This may help to diagnose and treat the complication in the early period, thus resulting in an improved prognosis for this potentially life-threatening complication of the posttransplant period.
subject
0Kidney Transplantation -- Adverse Effects
1Malaria -- Etiology
general
08958286
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
3MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline8958286
issn
000411337
10041-1337
rsrctypearticle
creationdate1996
addtitleTransplantation
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr4119961127
citationpf 1521 vol 62 issue 10
startdate19961127
enddate19961127
lsr30VSR-Enriched:[pqid, pages]
sort
titlePosttransplant malaria
authorTürkmen, A ; Sever, M S ; Ecder, T ; Yildiz, A ; Aydin, A E ; Erkoç, R ; Eraksoy, H ; Eldegez, U ; Ark, E
creationdate19961127
lso0119961127
facets
frbrgroupid8250209889336958214
frbrtype5
newrecords20190702
languageeng
creationdate1996
topic
0Kidney Transplantation–Adverse Effects
1Malaria–Etiology
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Türkmen, A
1Sever, M S
2Ecder, T
3Yildiz, A
4Aydin, A E
5Erkoç, R
6Eraksoy, H
7Eldegez, U
8Ark, E
jtitleTransplantation
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Türkmen
1Sever
2Ecder
3Yildiz
4Aydin
5Erkoç
6Eraksoy
7Eldegez
8Ark
aufirst
0A
1M S
2T
3A E
4R
5H
6U
7E
au
0Türkmen, A
1Sever, M S
2Ecder, T
3Yildiz, A
4Aydin, A E
5Erkoç, R
6Eraksoy, H
7Eldegez, U
8Ark, E
atitlePosttransplant malaria
jtitleTransplantation
risdate19961127
volume62
issue10
spage1521
pages1521-1523
issn0041-1337
formatjournal
genrearticle
ristypeJOUR
abstractThe frequency and clinical characteristics of plasmodium infection were reported in 420 renal transplant recipients who were followed in the Transplantation Unit and Out-Patient Clinic of the Medical School of Istanbul. Plasmodium infection was diagnosed in eleven (9 male, 2 female) of the 420 patients (2.6%). Ten of the patients were transplanted in India, and one in our institution. The mean duration between the transplantation and the diagnosis of malaria was 21.7 + 44.4 days in patients who were transplanted in India. All of the patients were taking triple immunosuppressive drugs (CsA, AZA, PRED). Plasmodium falciparum was diagnosed in 6 patients, P vivax in 1 patient and P malariae in 1 patient. Also mixed infection with P falciparum and P malariae was diagnosed in 3 patients. After definite diagnosis, the patients were hospitalized. Chloroquine phosphate plus primaquine phosphate was administered for P vivax infection, whereas chloroquine phosphate alone was given for P falciparum and P malariae infection as a first line antimalarial therapy. As a result of therapy, infection improved clinically and the plasmodia disappeared rapidly from the thick blood film in 10 of the patients. Severe hemolysis and acute renal failure developed in one patient, who improved after hemodialysis therapy and exchange transfusions. It was concluded that malaria is quite a frequent infection of transplant recipients who get their allografts from donors living in high-risk areas, and all transplant recipients having this kind of transplantations should be suspected and examined for malaria. This may help to diagnose and treat the complication in the early period, thus resulting in an improved prognosis for this potentially life-threatening complication of the posttransplant period.
pmid8958286
date1996-11-27